Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-F Chen

Showing results (391-400 of 393) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 393 results.
Paediatric and Perinatal Epidemiology|August 25, 2001
Socio-economic disparities in preterm birth: causal pathways and mechanismsM S Kramer, L Goulet, J Lydon, et al.
Breast Cancer Research and Treatment|June 17, 2016
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II studyL M Smyth, N M Iyengar, M F Chen, et al.
The New England Journal of Medicine|October 25, 2013
HLA-B*13:01 and the dapsone hypersensitivity syndromeF-R Zhang, H Liu, A Irwanto, et al.
Pageof 40

Showing results (391-400 of 393) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 393 results.
Paediatric and Perinatal Epidemiology|August 25, 2001
Socio-economic disparities in preterm birth: causal pathways and mechanismsM S Kramer, L Goulet, J Lydon, et al.
Breast Cancer Research and Treatment|June 17, 2016
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II studyL M Smyth, N M Iyengar, M F Chen, et al.
The New England Journal of Medicine|October 25, 2013
HLA-B*13:01 and the dapsone hypersensitivity syndromeF-R Zhang, H Liu, A Irwanto, et al.
Pageof 40